Stock market announcement archive

LIFE: Lifecare has initiated clinical studies of the smallest glucose sensor in the world for people diagnosed with diabetes

June 23, 2022
Bergen, Norway 23 June 2022Today, Lifecare AS will initiate first-in human clinical studies of the diabetessensor Sencell, thereby the second of two major milestones in 1H 2022 is inprogress. Lifecare recently announced that the first milestone for 1H 2022 wascompleted, namely successfully in-vitro testing and fabrication of the prototypehaving the size of a grain of […]
Read more

LIFE: Lifecare newsletter June and updated investor presentation

June 9, 2022
Bergen, Norway 9 June 2022 Lifecare has recently concluded successful in-vitro test results of theminiaturized Sencell sensor. This represents a milestone achievement of theSencell development, and the impact of the in-vitro tests reaches even further.Learn more about the importance of these test results, as well as furtherincrease of staff in the Lifecare Group, a nationwide […]
Read more

LIFE: Lifecare achieves milestone

June 2, 2022
Bergen, Norway 02 June 2022In the late hours of June 1st, 2022, the team at Lifecare NanoBioSenorsconcluded successful, high quality and reproducible in-vitro test results withthe miniaturized Sencell sensor for glucose measurement. This is a milestoneachievement confirming functionality of Lifecares proprietary technology both inthe nanoscale of the miniaturized sensors, as well as the signal readout […]
Read more

LIFE: Mandatory notification of trade

June 1, 2022
Bergen, Norway 1 June 2022Primary insider Joacim Holter has bought 25 000 shares at an average price of3,01 in Lifecare AS. Joacim Holter currently holds 272.997 shares in Lifecare AS, and after thetrade, Joacim Holter will hold a total of 297 997 shares in Lifecare AS. JoacimHolter also owns shares in Lifecare through his fully […]
Read more

LIFE: Lifecare Group incentive program established

May 23, 2022
Bergen, 23 May 2022On 6 May 2022, the Lifecare Annual General Meeting (AGM) passed a resolutionauthorizing the Board of Directors to establish an incentive program foremployees and consultants in the Lifecare Group. The AGM resolution included anauthorization for the Board to increase the share capital by up to 5% of theexisting registered share capital for […]
Read more

LIFE: Minutes from Annual General Meeting

May 6, 2022
Bergen, Norway 06 May 2022The Annual General Meeting of Lifecare AS was held both digitally and physicallyon Friday 06 May 2022 on the meeting platform Orgbrain. All proposals on theagenda were adopted, cf. the notification of the Annual General Meeting that waspublished on Oslo Stock Exchange on 22 April 2022. The complete minutes of theAnnual […]
Read more

LIFE: Registration of new share capital

May 3, 2022
Bergen, 03 May 2022Reference is made to the stock exchange announcement by Lifecare AS (the"Company") on 20 April 2022 regarding the share issue resolved by the board ofdirectors as part of the previously agreed consideration from Lifecare AS toacquire Lifecare Laboratories GmbH (formely named Pfützner Science and HealthGmbH). The share capital increase has now been […]
Read more

Lifecare AS: Notification of Annual General Meeting

April 22, 2022
Bergen, Norway 22 April 2022The Annual General Meeting ("AGM") of Lifecare AS will be held on 6 May 2022 at10:00 CET. Notice of the AGM is enclosed to this announcement. The meeting will be conducted as a combined physical and digital meeting.Shareholders who wish to participate and vote at the General Meeting must beregistered with […]
Read more

LIFE: Annual report 2021 and webcast

April 21, 2022
Bergen, Norway 21 April 2022Today, Lifecare 2021 annual report is published. 2021 was marked by severalimportant milestones: o Regulatory approval for first-in-human pilot clinical trials o Restructuring the organization - controlling development operationso Reinforced Patent Protection and IPo Successful Capital IncreaseThe report is subject to approval by the company's general meeting on 6 May2022.Lifecare AS' […]
Read more

Issuance of new shares to primary insider – in accordance with share purchase agreement prev. announced

April 20, 2022
Bergen, Norway 20 April 2022Islay Venture GmbH ("Islay), a company closely related to Lifecare's ChiefScientific Officer and primary insider Prof. Dr. Dr. med Andreas Pfützner, willsubscribe 1.756.876 new shares in Lifecare AS, as part of the previously agreedconsideration from Lifecare AS to acquire Lifecare Laboratories GmbH (formelynamed Pfützner Science and Health GmbH). The acquisition and […]
Read more